<DOC>
	<DOCNO>NCT01127178</DOCNO>
	<brief_summary>The purpose study determine maximum tolerate dose ( MTD ) poly ( ADP-Ribose ) polymerase inhibitor E7016 use temozolomide ( TMZ ) patient advance solid tumor gliomas .</brief_summary>
	<brief_title>Study Poly ( ADP-Ribose ) Polymerase ( PARP ) Inhibitor E7016 Combination With Temozolomide Subjects With Advanced Solid Tumors</brief_title>
	<detailed_description />
	<mesh_term>Temozolomide</mesh_term>
	<mesh_term>10- ( ( 4-hydroxypiperidin-1-yl ) methyl ) chromeno ( 4,3,2-de ) phthalazin-3 ( 2H ) -one</mesh_term>
	<mesh_term>Poly ( ADP-ribose ) Polymerase Inhibitors</mesh_term>
	<criteria>Subjects meet follow criterion may include study . 1 . Histopathologically confirm melanoma solid tumor ( exclude malignant brain tumor ) standard therapy available ( DoseEscalation Component ) . During Expansion Component , enrollment restrict subject histopathologically proven glioma include subject eligible TMZ therapy well fail TMZ therapy ; either appropriate candidate radiation therapy refuse radiation therapy . Subjects take either strong cytochrome P450 ( CYP ) inhibitor inducer may enrol . 2 . Life expectancy great equal 3 month start E7016 . 3 . Performance status ( PS ) 1 2 Eastern Cooperative Oncology Group ( ECOG ) scale . 4 . Adequate renal function indicate serum creatinine le 1.5 mg/dL calculate creatinine clearance great 50 mL/minute . 5 . Adequate bone marrow reserve : 1 . ANC great equal 1500/mm3 , 2 . Platelets great equal 100,000/mm3 ( without transfusion ) , 3 . Hemoglobin great equal 10 g/dL ( le 10.0 g/dL acceptable correct growth factor transfusion ) . 6 . Adequate liver function : 1 . Bilirubin le equal 1.5x upper limit normal ( ULN ) ( less equal 3 x ULN subject liver metastasis ) , 2 . Alkaline phosphatase , alanine aminotransferase ( ALT ) , aspartate aminotransferase ( AST ) less equal 3 time ULN ( less equal 5 x ULN subject liver metastasis ) . 7 . Males females age great equal 18 year time inform consent . 1 . Female subject childbearing potential must negative serum beta human chorionic gonadotropin ( BhCG ) test Visit 1 ( Screening ) negative urine pregnancy test prior first dose E7016 capsule SingleDose PK Period prior first dose E7016 Cycle 1 . 2 . Male subject partner woman childbearing potential must use partner must use highly effective method contraception ( eg , condom + spermicide , condom + diaphragm spermicide , IUD ) begin least 1 menstrual cycle prior start study drug ( ) , throughout entire study period , 30 day last dose study drug . Subjects meet follow criterion exclude participation study : 1 . Subjects primary metastatic brain tumor exclude DoseEscalation Component . 2 . Subjects active malignancy gliomas excluded Expansion Component . 3 . Subjects take medication either strong CYP inhibitor inducer exclude DoseEscalation Component . 4 . Prior treatment PARP inhibitor . 5 . Inability tolerate 150 mg/m2/d TMZ previous therapy TMZ . 6 . Known allergy , hypersensitivity , contraindication E7016 , TMZ , dacarbazine component formulation . 7 . Known human immunodeficiency virus infection , active hepatitis B C. 8 . Active infection require specific antiinfective therapy 9 . Subjects major surgical procedure ( include tumor resection ) within 4 week prior initiate E7016 treatment . 10 . Subjects schedule surgery project course study . 11 . Females pregnant ( positive BhCG test ) breastfeeding . 12 . Chemotherapy , radiation therapy , immunotherapy within 4 week prior initiate E7016 treatment ( 6 week mitomycin C nitrosoureas ) . 13 . Prolongation QTc interval ( 500 msec ) . 14 . Achlorhydria use antacid , protonpump inhibitor , drug know raise gastric pH within 2 week prior study drug administration . 15 . Any history concomitant medical condition clinically significant disease make subject medically unfit receive study drug , opinion investigator , unsuitable reason . 16 . Unable swallow multiple capsule . 17 . History drug alcohol dependency abuse within approximately last 2 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
</DOC>